Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Dose of Combination of Rocuronium and Cisatracurium
NCT02495038Completed
- Sponsor
- Yonsei University
- Start
- Mar 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of rocuronium and cisatracurium in Anesthesia (3 arms), sponsored by Yonsei University. Primary endpoints: Onset of Neuromuscular Blocking Agents, Duration 25% of Neuromuscular Blocking Agents and 1 more. Started Mar 2014; status: completed.
02
Drugs
rocuroniumcisatracurium
03
Conditions
Anesthesia
Beyond the preview
Go deeper on NCT02495038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02495038.